Cresco Labs Inc. (CRLBF)
OTCMKTS · Delayed Price · Currency is USD
1.240
-0.040 (-3.13%)
At close: Jan 9, 2026
Cresco Labs Market Cap
Cresco Labs has a market cap or net worth of $455 million as of January 9, 2026. Its market cap has increased by 50.31% in one year.
Market Cap
455.00M
Enterprise Value
903.24M
Revenue
661.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.24
Market Cap Chart
Since December 3, 2018, Cresco Labs's market cap has decreased from 627.84M to 455.00M, a decrease of -27.53%. That is a compound annual growth rate of -4.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 455.00M | 4.61% |
| Dec 31, 2025 | 434.93M | 35.91% |
| Dec 31, 2024 | 320.01M | -30.65% |
| Dec 29, 2023 | 461.48M | -15.53% |
| Dec 30, 2022 | 546.30M | -71.66% |
| Dec 31, 2021 | 1.93B | -17.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 503.78M |
| Northwest Biotherapeutics | 445.03M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 365.15M |
| Silence Therapeutics | 273.96M |